Skip to Content

Dabrafenib (Tafinlar) and Trametinib (Mekinist)

Treatment Taken by Mouth

Generic : Dabrafenib (duh-BRA-feh-nib) and Trametinib (truh-MEH-tih-nib)
Brand : Tafinlar (TA-fin-lar) and Mekinist (MEH-kih-nist)
Download In :
Download 0.44MB
Last Update : February 06, 2026

About this Treatment

The combination of dabrafenib and trametinib is used for solid tumors with certain types of abnormal “BRAF” gene.

What are Patient Education Sheets (PES)?

A Patient Education Sheet (PES) is a practical tool created with the unique needs of patients with cancer in mind. Each sheet translates complex treatment information into clear, patient-friendly language. They provide easy-to-follow medication schedules and guidance on managing potential side effects, helping patients and their caregivers feel informed and supported.

These resources are pulled directly by healthcare providers, who can download and print them for distribution during patient visits. This ensures that patients and caregivers leave the clinic with a reliable, easy-to-understand reference tailored to their treatment.

In addition to the standard content, PES documents are also editable in designated sections. Providers can add personalized details such as counseling notes, local resources, or contact information, making each sheet specific to the patient’s care journey.